These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 94894

  • 1. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M, Lukjan H, Myśliwiec M, Dabrowski S.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [Abstract] [Full Text] [Related]

  • 2. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M, Myśliwiec M, Perzanowski A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract] [Full Text] [Related]

  • 3. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M, Bodzenta A, Lukjan H, Kiersnowska-Rogowska B, Kłoczko J, Myśliwiec M, Dabrowski S, Tymiński W, Czestochowska E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [Abstract] [Full Text] [Related]

  • 4. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
    Jarrett PE, Morland M, Browse NL.
    Br Med J; 1977 Apr 09; 1(6066):933-4. PubMed ID: 856391
    [Abstract] [Full Text] [Related]

  • 5. [The 131I-fibrinogen turnover during activation of blood fibrinolysis].
    Grabowski R, Bielawiec M, Kiersnowska B, Lukjan H, Perzanowski A, Mysliwiec M, Korfel B, Rogowski F.
    Z Gesamte Inn Med; 1976 Dec 15; 31(24):1025-7. PubMed ID: 1020408
    [Abstract] [Full Text] [Related]

  • 6. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS.
    Acta Univ Carol Med Monogr; 1972 Dec 15; 52():19-23. PubMed ID: 4669824
    [No Abstract] [Full Text] [Related]

  • 7. Prospective study of a phenformin-like substance (moroxydine chloride) in patients with deficient vessel wall fibrinolysis.
    Tengborn L, Hedner U, Nilsson IM.
    J Med; 1982 Dec 15; 13(5-6):353-64. PubMed ID: 6963328
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
    Chakrabarti R.
    Acta Univ Carol Med Monogr; 1972 Dec 15; 53():261-2. PubMed ID: 4670736
    [No Abstract] [Full Text] [Related]

  • 9. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia.
    Ciświcka-Sznajderman M, Berent H, Rymaszewski Z.
    Atherosclerosis; 1974 Dec 15; 19(1):153-9. PubMed ID: 4359182
    [No Abstract] [Full Text] [Related]

  • 10. Immunologic study of fibrinogen and its split products in venous thrombosis.
    Sova J.
    Acta Univ Carol Med Monogr; 1972 Dec 15; 52():173-9. PubMed ID: 4593289
    [No Abstract] [Full Text] [Related]

  • 11. [Non-enzymatic fibrinolytic agents].
    Nilsson IM, Hedner U.
    Ann Anesthesiol Fr; 1978 Dec 15; 19(8):697-702. PubMed ID: 31113
    [Abstract] [Full Text] [Related]

  • 12. Effects on platelet stickiness and fibrinolysis of phenformin combined with ethyloestrenol or stanozolol.
    Chakrabarti R, Fearnley GR, Evans JF.
    Lancet; 1970 Mar 21; 1(7647):591-3. PubMed ID: 4190544
    [No Abstract] [Full Text] [Related]

  • 13. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Nilsson IM, Isacson S.
    J Clin Pathol; 1972 Jul 21; 25(7):638-9. PubMed ID: 5070268
    [No Abstract] [Full Text] [Related]

  • 14. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
    Sue-Ling HM, Davies JA, Prentice CR, Verheijen JH, Kluft C.
    Thromb Haemost; 1985 Feb 18; 53(1):141-2. PubMed ID: 3873118
    [Abstract] [Full Text] [Related]

  • 15. Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs.
    Warlow CP, Rennie JA, Ogston D, Douglas AS.
    Thromb Haemost; 1976 Aug 31; 36(1):127-32. PubMed ID: 1036801
    [Abstract] [Full Text] [Related]

  • 16. The value of phenformin and ethyloestrenol in the prevention of deep venous thrombosis in patients undergoing surgery.
    Atkins P, Brown IK, Downie RJ, Haggart BG, Littler J, Robb PM, Santer GJ, Jones I.
    Thromb Haemost; 1978 Feb 28; 39(1):89-96. PubMed ID: 580509
    [Abstract] [Full Text] [Related]

  • 17. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B, Cunliffe WJ, Roberts BE, Sibbald R.
    Br Med J; 1973 Apr 14; 2(5858):82-4. PubMed ID: 4573315
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 14; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 19. Phenformin and ethyloestrenol in recurrent venous thrombosis.
    Nilsson IM, Hedner U, Isacson S.
    Acta Med Scand; 1975 Feb 14; 198(1-2):107-13. PubMed ID: 1166815
    [Abstract] [Full Text] [Related]

  • 20. Prophylaxis of venous thromboembolism.
    Kakkar VV.
    Proc R Soc Med; 1975 Apr 14; 68(4):263-4. PubMed ID: 1197329
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.